Attalla, S. A., Isaac, K. J., Pfeffer, M., Hockaday, J. R., Weatherly, R., Asselin, M. B., Lewis, A. K., Rai, V., Jr, W. A. H., Long, M. H., Placide, T., Pearce, K. R., Nkengbeza, L. N., Thurman, A. K., Cox, A. L., Diaz, G. D., Carter, J., Stein, N., Fischer, S., Ellis, B. L. (2026). Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths. PLoS ONE. https://doi.org/10.1371/journal.pone.0346795